Scarica l'app Stockscreener
2.16
2.86%
0.06
Dopo l'orario di chiusura:
2.12
-0.04
-1.85%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRBU Giù?
Forum
Previsione
Caribou Biosciences Inc Borsa (CRBU) Ultime notizie
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $11 - Moomoo
CRBU SEC FilingsCaribou Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
CRBU: Allogeneic CAR T programs show strong clinical progress and are advancing toward pivotal trials - TradingView
Caribou Biosciences stock (US1420381089): Q1 update and CRISPR pipeline stay in focus - AD HOC NEWS
CRBU Technical Analysis & Stock Price Forecast - Intellectia AI
Caribou Biosciences brings CMO and CFO to BioConnect Investor Conference fireside chat - Traders Union
CRBU Technical Analysis | Trend, Signals & Chart Patterns | CARIBOU BIOSCIENCES INC (NASDAQ:CRBU) - ChartMill
Caribou Biosciences stock (US1420381089): fresh data from latest CAR?T update keeps investors watchi - AD HOC NEWS
Transcript : Caribou Biosciences, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 08 - marketscreener.com
Caribou Biosciences (CRBU) price target increased by 38.57% to 12.37 - MSN
Caribou Biosciences stock (US1420381089): Q1 earnings beat and 4.4% surge - AD HOC NEWS
May 2026's Promising Penny Stocks - Yahoo Finance
Bank of America Securities Remains a Buy on Caribou Biosciences (CRBU) - The Globe and Mail
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference - The Manila Times
Caribou Biosciences attends BioConnect Investor Conference in New York next week - Traders Union
CRISPR biotech Caribou Biosciences plans H.C. Wainwright talk May 19 - Stock Titan
Need To Know: Analysts Are Much More Bullish On Caribou Biosciences, Inc. (NASDAQ:CRBU) Revenues - simplywall.st
Industry Analysts Just Upgraded Their Caribou Biosciences, Inc. (NASDAQ:CRBU) Revenue Forecasts By 30% - Moomoo
Industry Analysts Just Made A Massive Upgrade To Their Caribou Biosciences, Inc. (NASDAQ:CRBU) Revenue Forecasts - Yahoo Finance
EHA2026 spotlights Caribou Biosciences advances in allogeneic CAR-T treatments for lymphoma and multiple myeloma - Traders Union
Caribou Biosciences, Inc. Announces Acceptance of Two Oral Presentations at the 2026 European Hematology Association Annual Meeting - Quiver Quantitative
Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting - The Manila Times
Caribou Biosciences CEO Rachel Haurwitz to join Bank of America conference fireside chat - Traders Union
H.C. Wainwright Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Raises Target Price to $11 - Moomoo
Q4 EPS Forecast for Caribou Biosciences Lowered by Analyst - MarketBeat
MSN Money - MSN
Caribou Biosciences (NASDAQ:CRBU) Issues Quarterly Earnings Results - MarketBeat
Caribou Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Caribou Biosciences 報告了2026年第一季度的財務業績並提供了業務更新。 - Moomoo
RBC Capital Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $10 - Moomoo
BofA Securities Maintains Caribou Biosciences(CRBU.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Caribou Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update - Investing News Network
Caribou Biosciences, Inc. (CRBU) reports Q1 loss, misses revenue estimates - MSN
Caribou Biosciences : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
Caribou Biosciences (NASDAQ: CRBU) trims Q1 2026 loss, holds $118.6M cash - Stock Titan
Caribou Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Caribou secures FDA alignment on phase 3 trial, sees cash into 2H 2027 - Stock Titan
Caribou Biosciences (NASDAQ: CRBU) trims Q1 loss, holds $118.6M cash - Stock Titan
Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference - The Manila Times
Caribou Biosciences to participate in BofA Securities Health Care event in Las Vegas - Traders Union
Caribou Biosciences (CRBU) price target decreased by 22.79% to 8.92 - MSN
Caribou Biosciences Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
Caribou Biosciences (CRBU) corrects record‑date shares, June 17 virtual annual meeting - Stock Titan
0.98%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):